Happy to here that the low P1 enrollment for NEO is nothing to be concerned about.
Unfortunately for ADXS they're going to need knockout data from HOT/NEO to get this thing out of its hole. There may not be enough time left given their situation for them to even see that. Petit gone also doesn't look good.
Quick question Hovacare, might these patients response to vaccine strengthen as their immune systems get trained and becomes more competent? Might we see some of these stable disease patients become partial and complete responders as time goes by? Just looking for your opinion on that.